Recommendations for the use of new methods to assess the efficacy of disease-modifying drugs in the treatment of osteoarthritis
- 1 April 2004
- journal article
- review article
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 12 (4) , 263-268
- https://doi.org/10.1016/j.joca.2004.01.006
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Structural and Symptomatic Efficacy of Glucosamine and Chondroitin in Knee OsteoarthritisArchives of internal medicine (1960), 2003
- Detection of radiographic joint space narrowing in subjects with knee osteoarthritis: Longitudinal comparison of the metatarsophalangeal and semiflexed anteroposterior viewsArthritis & Rheumatism, 2003
- Osteoarthritis: biological markers for the future?Joint Bone Spine, 2002
- Glucosamine Sulfate Use and Delay of Progression of Knee OsteoarthritisArchives of internal medicine (1960), 2002
- Imaging of the disease processCurrent Opinion in Rheumatology, 2002
- The prevalence and burden of arthritisRheumatology, 2002
- Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trialArthritis & Rheumatism, 2001
- Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trialThe Lancet, 2001
- Efficacy and safety of diacerein in osteoarthritis of the knee: A double-blind, placebo-controlled trialArthritis & Rheumatism, 2000
- Recommendations for the registration of drugs used in the treatment of osteoarthritis. Group for the respect of ethics and excellence in science (GREES): osteoarthritis section.Annals of the Rheumatic Diseases, 1996